Quaker BioVentures' Sherrill Neff Elected to NVCA Board of Directors

Business Wire, April 30, 2009

BOSTON & PHILADELPHIA -- Quaker BioVentures, a leading venture capital firm dedicated to investing in life science companies in the Mid-Atlantic region, today announced that founding Partner Sherrill Neff has been named to the National Venture Capital Association (NVCA) board of directors. The announcement was made at the 2009 NVCA Annual Meeting today in Boston at the Westin Boston Waterfront Hotel.

Since founding Quaker BioVentures with Brenda Gavin and Ira Lubert in 2002, Neff has been one of the most active contributors to the venture community regionally, helping to foster the growth of a number of life science companies and bringing new medical innovations to market. He has also been involved with the NVCA, assisting in its public policy and legislative efforts in Washington, D.C., and serving as a regular commentator to the press on venture capital and life science matters.

Prior to forming Quaker BioVentures, Neff was President and Chief Operating Officer of Neose Technologies. He also served as Senior Vice President, Corporate Development at U.S. Healthcare, and Managing Director in the investment banking division of Alex. Brown & Sons. Earlier in his career, Neff worked as a corporate attorney at Morgan, Lewis & Bockius.

At Quaker BioVentures, Neff's current portfolio company board responsibilities include Amicus Therapeutics, Biolex Therapeutics, Neuronetics, Optherion, and Regado Biosciences. He is also a board observer for Argolyn. Previously, he has served on the boards of BioRexis Pharmaceutical Corporation and Medmark.

Neff has also formerly served as the Chairman of the Greater Philadelphia Venture Group, now the Mid-Atlantic Capital (MAC) Alliance, and the President of the Pennsylvania Biotechnology Association, now PA Biotech. He is currently a board member of Resource Capital Corporation (NYSE: RSO), University City Science Center, Biotechnology Institute, the Policy Board of WXPN and Vesper Boat Club. He is a former board member of several publicly traded companies, including Resource America, The Bancorp, Jefferson Bank, and Neose Technologies.

Neff received a B.A. from Wesleyan University and J.D. magna cum laude from the University of Michigan Law School.

About Quaker BioVentures

Quaker BioVentures is a venture capital firm with $700 million under management, dedicated to investing in life science companies in the Mid-Atlantic region and contiguous states. The firm leads investments in companies across the spectrum of the life science industry, including biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals, and healthcare services. Quaker BioVentures invests in companies at all stages of development, from early stage businesses to public companies. Please visit Quaker BioVentures’ website at www.quakerbio.com.

About National Venture Capital Association

The National Venture Capital Association (NVCA) represents approximately 450 venture capital firms in the United States. NVCA's mission is to foster greater understanding of the importance of venture capital to the U.S. economy and support entrepreneurial activity and innovation. According to a 2009 Global Insight study, venture-backed companies accounted for 12.1 million jobs and $2.9 trillion in revenue in the United States in 2008. The NVCA represents the public policy interests of the venture capital community, strives to maintain high professional standards, provides reliable industry data, sponsors professional development, and facilitates interaction among its members. For more information about the NVCA, please visit www.nvca.org.